Ironwood Pharmaceuticals | IRWD - Current Assets


Ironwood Pharmaceuticals reported $273.84M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Acadia Pharmaceuticals USD 1.08B 115.87M Sep/2025
Agios Pharmaceuticals USD 1.03B 13.64M Sep/2025
Almirall EUR 714.05M 27.09M Jun/2025
Alnylam Pharmaceuticals USD 3.95B 309.11M Sep/2025
Amarin USD 628.33M 21.52M Sep/2025
Ardelyx USD 367.98M 16.42M Sep/2025
Astellas Pharma JPY 1.37T 75.51B Sep/2025
AstraZeneca USD 29.94B 1B Sep/2025
Charles River Laboratories USD 1.53B 62.24M Sep/2025
Exact Sciences USD 1.59B 82.87M Sep/2025
Halozyme Therapeutics USD 1.33B 206.08M Sep/2025
Incyte USD 4.28B 634.19M Sep/2025
Ironwood Pharmaceuticals USD 273.84M 82.09M Sep/2025
MacroGenics USD 232.09M 27.15M Sep/2025
Moderna USD 6.6B 427M Sep/2025
Myriad Genetics USD 344.8M 60.5M Sep/2025
Pacira USD 562.75M 182.86M Sep/2025
PTC Therapeutics USD 2.01B 265.07M Sep/2025
Sarepta Therapeutics USD 2.72B 65.32M Sep/2025
Takeda JPY 3.12T 195.82B Dec/2025
Ultragenyx Pharmaceutical USD 643.21M 76.58M Sep/2025